41 completed, 10 terminated, 2 withdrawn, 1 unknown. 54 Phase 1, 18 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 54 | Completed 41, Terminated 10, Withdrawn 2, Unknown 1 |
| Phase 2 | 18 | Completed 12, Terminated 5, Unknown 1 |
Follow immunohistochemistry staining method: new trials by email Literature Review of immunohistochemistry staining method trials Research Report on immunohistochemistry staining method
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod HLA-A2 restricted synthetic tumor antigen, Imiquimod, enzyme-linked immunosorbent assay - Ependymoma | Phase 1 | Terminated | James Felker | 23 | 2012-08-01 | 2026-02-05 |
| FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Oxaliplatin, Irinotecan, Leucovorin - Pancreatic Neoplasms | Phase 1 | Completed | Washington University School of Medicine | 44 | 2012-04-01 | 2016-09-19 |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma cyclophosphamide, aldesleukin, autologous tumor cell vaccine - Recurrent Melanoma, Stage IV Melanoma | Phase 1 | Completed | Fred Hutchinson Cancer Center | 12 | 2012-03-01 | 2014-04-21 |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer fluorouracil, leucovorin calcium, oxaliplatin - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 / Phase 2 | Completed | City of Hope Medical Center | 6 | 2012-02-01 | 2017-05-31 |
| Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy everolimus, erlotinib hydrochloride, biopsy - Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer | Phase 1 | Withdrawn | Fox Chase Cancer Center | 2011-04-01 | 2023-04-04 | |
| Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma everolimus, lenalidomide, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 / Phase 2 | Completed | Mayo Clinic | 58 | 2011-01-10 | 2020-10-22 |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases bafetinib, microdialysis, pharmacological study - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | City of Hope Medical Center | 7 | 2010-12-01 | 2018-04-17 |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia entinostat, imatinib mesylate, laboratory biomarker analysis - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 2 | 2010-10-01 | 2017-08-08 |
| Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer letrozole, panobinostat, RNA analysis - Breast Cancer | Phase 1 / Phase 2 | Completed | Alliance for Clinical Trials in Oncology | 28 | 2010-09-01 | 2017-06-27 |
| A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas flucytosine, polymerase chain reaction, immunohistochemistry staining method - Adult Anaplastic Astrocytoma, Recurrent Grade III Glioma | Phase 1 | Completed | City of Hope Medical Center | 15 | 2010-08-01 | 2017-11-09 |
| Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma azacitidine, lenalidomide, dexamethasone - Refractory Multiple Myeloma | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 45 | 2010-06-01 | 2020-11-16 |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate panobinostat, everolimus, laboratory biomarker analysis - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 26 | 2010-03-01 | 2022-08-15 |
| AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors multikinase inhibitor AT9283, enzyme-linked immunosorbent assay, immunohistochemistry staining method - Unspecified Childhood Solid Tumor, Protocol Specific | Phase 1 | Completed | Cancer Research UK | 33 | 2009-09-01 | 2019-11-29 |
| Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast vorinostat, protein expression analysis, immunohistochemistry staining method - Breast Cancer | Phase 1 | Completed | University of California, San Francisco | 17 | 2009-07-01 | 2017-08-07 |
| Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma therapeutic autologous lymphocytes, aldesleukin, denileukin diftitox - Recurrent Melanoma, Stage III Melanoma | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 3 | 2009-07-01 | 2022-11-15 |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study - Prostate Cancer | Phase 1 | Terminated | Cancer Research UK | 8 | 2009-06-01 | 2012-02-28 |
| Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery systemic chemotherapy, RNA analysis, gene expression analysis - Colorectal Cancer | Phase 1 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2009-06-01 | 2013-04-16 | |
| Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer decitabine, NY-ESO-1 peptide vaccine, pegylated liposomal doxorubicin hydrochloride - Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2009-04-01 | 2022-08-01 |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer bevacizumab, FOLFOX regimen, fluorouracil - Colorectal Cancer | Phase 1 | Completed | City of Hope Medical Center | 11 | 2009-03-11 | 2025-06-22 |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma epirubicin hydrochloride, ifosfamide, sorafenib tosylate - Sarcoma | Phase 1 | Completed | OHSU Knight Cancer Institute | 18 | 2009-02-01 | 2018-09-07 |
Showing 20 of 54. Sign in to see all of them.
Breast Neoplasms (7) · Melanoma (7) · Prostatic Neoplasms (4) · Astrocytoma (3) · Brain Neoplasms (3) · Breast Neoplasms, Male (3) · Burkitt Lymphoma (3) · Carcinoma, Ovarian Epithelial (3) · Carcinoma, Renal Cell (3) · Glioblastoma (3) · Gliosarcoma (3) · Head and Neck Neoplasms (3) · Lung Neoplasms (3) · Lymphoma, B-Cell, Marginal Zone (3) · Lymphoma, Follicular (3)
City of Hope Medical Center (9) · Fred Hutchinson Cancer Center (4) · Memorial Sloan Kettering Cancer Center (3) · NCIC Clinical Trials Group (3) · National Cancer Institute (NCI) (3) · University of California, Davis (3) · Abramson Cancer Center at Penn Medicine (2) · Cancer Research UK (2) · Case Comprehensive Cancer Center (2) · Mayo Clinic (2) · Roswell Park Cancer Institute (2) · University of California, San Francisco (2) · AIDS Malignancy Consortium (1) · Alliance for Clinical Trials in Oncology (1) · Barbara Ann Karmanos Cancer Institute (1)
United States (42) · Canada (4) · United Kingdom (2) · Belgium (1) · Ireland (1) · Switzerland (1)
Angela Davies, MD (2) · Cassian Yee (2) · Jana Portnow (2) · Sylvia Lee (2) · Ahmad Awada, MD, PhD (1) · Amit Maity (1) · Andrea Wang-Gillam, M.D., PhD (1) · Anthony Fyles, MD (1) · Arthur Blackstock (1) · Aude Chapuis (1) · Bhaumik B. Patel, MD (1) · Brian H. Kushner, MD (1) · Christopher W. Ryan, MD (1) · Craig Reeder, M.D. (1) · Darren Hargrave, MD (1)
PMID 18090584, PMID 21285985, PMID 22044694, PMID 22160854, PMID 22989664, PMID 23380277, PMID 26774555, PMID 27055731, PMID 27269940, PMID 28679643, PMID 31436839, PMID 31654285, PMID 34944886
P30CA033572 (4), K12CA076930 (3), P30CA093373 (2), N01CN35158 (1), P30CA015083 (1), P30CA016086 (1), P30CA043703 (1), P30CA069533 (1), P30CA072720 (1), P50CA107399 (1), R01CA174858 (1), R21CA128283 (1), R21CA137647 (1), U01CA062490 (1), U01CA070095 (1)